The Tianjin Eye Hospital
Tianjin, 300020, China
NCT Number: NCT00762970
This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.
Looking for future studies?
Notify Me8 year–12 year
All sexes
Interventional
Not applicable
Tianjin, 300020, China
The study will be a prospective, randomized, single blind, bilateral dispensing study
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigational soft contact lens with asperic optical design to control myopia progression.
Investigational soft contact lens with asperic optical design to control myopia progression.
Spectacle Lenses.
Time frame: Baseline and every 6 months post-baseline for 2 years
Spherical equivalent refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor (WAM-5500) and descriptively summarized for each follow-up. Higher spherical refraction indicates progression in Myopia.
Time frame: Baseline and every 6 months post-baseline for 2 years
Axial length was measured with the IOLMaster at baseline and every 6 months post-baseline for 2 years. Axial length was descriptively summarized for each follow-up.
Johnson & Johnson Vision Care, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details